As I and others have speculated all along, the 6 cohort design could lead to some or all of the 3 T315i cohorts being ended early for that specific indication. We're talking months for them to prove improvements over no treatment (as none exists).
I did step away for a few minutes and volume shot up 10 fold...looking for 7.50+ today, holding the gains.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.